Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sangole PN
Therapeutic Promise of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor in a Preclinical Model of Colon Carcinogenesis
Clinical and Experimental Pharmacology
Related publications
Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays
Thrombosis and Haemostasis
Hematology
Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
New Oral Antithrombotics: Focus on Dabigatran, an Oral, Reversible Direct Thrombin Inhibitor for the Prevention and Treatment of Venous and Arterial Thromboembolic Disorders
Vascular Health and Risk Management
Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring
Thrombosis and Haemostasis
Hematology
An Unusual Side Effect of Dabigatran Etexilate Use - Acute Renal Failure
Eurasian Journal of Emergency Medicine
New Options With Dabigatran Etexilate in Anticoagulant Therapy
Vascular Health and Risk Management
Effect of the Oral Thrombin Inhibitor Dabigatran on Allergic Lung Inflammation Induced by Repeated House Dust Mite Administration in Mice
American Journal of Physiology - Lung Cellular and Molecular Physiology
Pulmonary
Respiratory Medicine
Physiology
Cell Biology
Rivaroxaban: An Oral Direct Inhibitor of Factor Xa
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Dabigatran Inhibits Intravitreal Thrombin Activity
Acta Ophthalmologica
Medicine
Ophthalmology
